Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AMWL
BuyHot AirAmerican Well Corporation · Healthcare · United States · $203M · Avg Vol: $1M/d
COMPANY DESCRIPTION
American Well Corporation (Amwell) provides an enterprise-grade telehealth platform that enables digital care delivery for health systems, health plans, and innovators. The company's competitive moat is its highly integrated, white-label Amwell Converge platform, which embeds directly into existing clinical workflows. It operates as a leading B2B digital health technology provider in the United States.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 277.2M | 259.0M | 254.4M | 249.3M | -3.5% | 218.5M | 203.2M | 210.6M | -8.1% |
| EPS | -19.80 | -47.60 | -13.88 | -5.96 | — | -4.78 | -2.56 | -1.58 | — |
| Shares | 13.9M | 14.4M | 15.6M | 16.4M | +18.6% | 15.4M | — | — | — |
| Debt | 14.8M | 11.8M | 8.2M | 4.5M | -32.7% | 3.0M | — | — | — |
| Equity | 1.1B | 464.2M | 304.8M | 235.6M | -39.5% | — | — | — | — |
| Op CF | -192.3M | -148.3M | -127.3M | -66.0M | — | -26.4M | — | — | — |
| Inv CF | -11.6M | -19.2M | -18.7M | 17.1M | — | — | — | — | — |
| Fin CF | -3.6M | 2.1M | 1.4M | 0.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AMWL are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AMWL | American Well Corporation(you) | $203M | 75 | Buy |
| OPRX | OptimizeRx Corporation | $150M | 77 | Buy |
| CCLD | CareCloud, Inc. | $106M | 77 | Buy |
| SPOK | Spok Holdings, Inc. | $223M | 90 | Strong Buy |
| NRC | NRC Health | $483M | 73 | Buy |
| SLP | Simulations Plus, Inc. | $372M | 83 | Strong Buy |
| NURS.V | Hydreight Technologies Inc. | $147M | 59 | Hold |
| WEAV | Weave Communications, Inc. | $583M | 64 | Hold |
| CTEV | Claritev Corporation | $668M | 66 | Buy |
| GDRX | GoodRx Holdings, Inc. | $1.2B | 77 | Buy |
Peer medians: ROE -30.8% · P/E 27.0x · Gross margin 58.3%